Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Compensatory activity of the PC-ME1 metabolic axis underlies differential sensitivity to mitochondrial complex I inhibition.
Del Prado L, Jaraíz-Rodríguez M, Agro M, Zamora-Dorta M, Azpiazu N, Calleja M, Lopez-Manzaneda M, de Juan-Sanz J, Fernández-Rodrigo A, Esteban JA, Girona M, Quintana A, Balsa E. Del Prado L, et al. Among authors: jaraiz rodriguez m. Nat Commun. 2024 Oct 7;15(1):8682. doi: 10.1038/s41467-024-52968-1. Nat Commun. 2024. PMID: 39375345 Free PMC article.
Erratum to "Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283" [EBioMedicine 62, December 2020] DOI: https://doi.org/10.1016/j.ebiom.2020.103134.
Pelaz SG, Jaraíz-Rodríguez M, Álvarez-Vázquez A, Talaverón R, García-Vicente L, Flores-Hernández R, de Cedrón MG, Tabernero M, de Molina AR, Lillo C, Medina JM, Tabernero A. Pelaz SG, et al. Among authors: jaraiz rodriguez m. EBioMedicine. 2021 Dec;74:103752. doi: 10.1016/j.ebiom.2021.103752. Epub 2021 Dec 12. EBioMedicine. 2021. PMID: 34911027 Free PMC article. No abstract available.
Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43266-283.
Pelaz SG, Jaraíz-Rodríguez M, Álvarez-Vázquez A, Talaverón R, García-Vicente L, Flores-Hernández R, Gómez de Cedrón M, Tabernero M, Ramírez de Molina A, Lillo C, Medina JM, Tabernero A. Pelaz SG, et al. Among authors: jaraiz rodriguez m. EBioMedicine. 2020 Dec;62:103134. doi: 10.1016/j.ebiom.2020.103134. Epub 2020 Nov 27. EBioMedicine. 2020. PMID: 33254027 Free PMC article.
Erratum to 'Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo'.
Jaraíz-Rodríguez M, Talaverón R, García-Vicente L, Pelaz SG, Domínguez-Prieto M, Álvarez-Vázquez A, Flores-Hernández R, Sin WC, Bechberger J, Medina JM, Naus CC, Tabernero A. Jaraíz-Rodríguez M, et al. Neuro Oncol. 2021 Aug 2;23(8):1414. doi: 10.1093/neuonc/noaa087. Neuro Oncol. 2021. PMID: 32515482 Free PMC article. No abstract available.
Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo.
Jaraíz-Rodríguez M, Talaverón R, García-Vicente L, Pelaz SG, Domínguez-Prieto M, Álvarez-Vázquez A, Flores-Hernández R, Sin WC, Bechberger J, Medina JM, Naus CC, Tabernero A. Jaraíz-Rodríguez M, et al. Neuro Oncol. 2020 Apr 15;22(4):493-504. doi: 10.1093/neuonc/noz243. Neuro Oncol. 2020. PMID: 31883012 Free PMC article.
11 results